How to invest in compass pathways
Web13 apr. 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for COMPASS Pathways stock is Buy based on the current 5 buy ratings for CMPS. The average twelve-month price prediction for COMPASS Pathways is $47.00 with a high price target of $120.00 and a low price target of $19.00. Web14 apr. 2024 · PFS Investments Inc. lifted its holdings in COMPASS Pathways by 14.4% during the fourth quarter. PFS Investments Inc. now owns 56,756 shares of the company’s stock worth $456,000 after buying an ...
How to invest in compass pathways
Did you know?
Web9 nov. 2024 · Compass Pathways stock plunged Tuesday, even as the London-based psychedelic-drug developer said a strong dose of its psilocybin-based drug helped … Web12 apr. 2024 · If you want to know who really controls COMPASS Pathways plc (NASDAQ:CMPS), then you'll have to look at the makeup of its share registry. Large …
Web28 mrt. 2024 · CMPS: COMPASS Pathways broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. WebCOMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Their focus is on improving the …
Web12 apr. 2024 · Fintel reports that on April 12, 2024, EF Hutton reiterated coverage of COMPASS Pathways Plc American Depository Shares (NASDAQ:CMPS) with a Buy recommendation. Web11 mei 2024 · Compass Pathways uses psychoactive treatment for depression — CEO explains. O’Leary said investors also need to remember these are nascent businesses with a high degree of risk, and that ...
WebTo buy shares in COMPASS Pathways you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell.
Web12 mrt. 2024 · COMPASS Pathways Engaged Employer Overview 70 Reviews 5 Jobs 14 Salaries 6 Interviews 2 Benefits 10 Photos + Add a Review COMPASS Pathways Reviews Updated 12 Mar 2024 Find Reviews Clear All Full-time, Part-time English Filter Found 53 of over 70 reviews Sort Popular Popular Highest Rating Lowest Rating Most Recent Oldest … pooh shiesty lil babyWeb19 jul. 2024 · COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2024. George Goldsmith, COMPASS’ current CEO and Chairman, … shap summary plot show all featuresWeb11 apr. 2024 · CMPS News Today Why did COMPASS Pathways stock go up today? Financial Calendars Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings Stock Ratings by Company Stock Ratings by Issuer Stock Ratings Screener Top-Rated Stocks Lowest-Rated Stocks Top-Rated Analysts Top-Rated Brokerages Most-Upgraded Stocks … shap summary plot save figureWeb14 apr. 2024 · COMPASS Pathways (NASDAQ:CMPS – Get Rating) ‘s stock had its “buy” rating reiterated by EF Hutton Acquisition Co.I in a research note issued on Wednesday, Benzinga reports. They currently ... shap summary plot feature orderWeb11 nov. 2024 · Compass Pathways has seen its shares slide in a big way this year. The drugmaker, however, has made significant progress on the clinical front in 2024. This … pooh shiesty jail updateWeb11 apr. 2024 · Compass Pathways PLC Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $10.55 +0.06 (+0.57%) Updated Apr 10, 2024 1W + 6.57% 1M + 36.13% 3M + 25.15% 1Y - 15.8% CMPS Price $10.55 Fair Value Price N/A Market Cap $451.16M 52 Week Low $6.54 52 Week High $21.50 P/E -4.88x P/B 2.49x P/S N/A … pooh shiesty lil durkWeb4 nov. 2024 · Compass Pathways Stock. Shares closed off session highs but still jumped 8.9% to close at 35.94 in the stock market today.Compass Pathways stock is in an IPO base with a 47.39 entry. pooh shiesty lawyer